Daniel Corey is the founder of Cero Therapeutics. Cero Therapeutics has raised $40M in total funding. Latest round: Series A.
Daniel Corey is the co-founder of Cero Therapeutics, a clinical-stage biotechnology company based in San Francisco, California. The company focuses on developing engineered T-cell immunotherapies for hematological and solid tumor cancers. Cero Therapeutics has raised $40 million in Series A funding and went public on Nasdaq through a SPAC merger with Phoenix Biotech Acquisition Corp.
Full founder directory · Investor directory · Company funding database · Fundraising library